Press Releases | Medtronic

Month Year

Email alerts

Jun 2, 2010

New Data in the New England Journal of Medicine Show Medtronic Deep Brain Stimulation Provides Sustained Motor Function Improvement in Parkinson's Disease

MINNEAPOLIS, Jun 02, 2010 (BUSINESS WIRE) --In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor...
May 30, 2010

Medtronic Achieves Enrollment Milestone in 'CURE-AF'

Clinical Trial of Surgical Tissue Ablation Includes Two U.S. IDE Studies

MINNEAPOLIS, May 03, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced completion of patient enrollment in the first of two studies in the company's CURE-AF (Concomitant...
May 26, 2010

Medtronic CoreValve(R) System Shows Long-Term Efficacy and Durability in Pivotal Trial

Medtronic CoreValve(R) System Shows Long-Term Efficacy and Durability in Pivotal Trial

PARIS, May 26, 2010 (BUSINESS WIRE) --New clinical data presented today at EuroPCR demonstrate positive long-term performance and durability for the CoreValve transcatheter aortic valve...
May 25, 2010

Record Fourth Quarter Caps Strong Year for Medtronic

International Revenue Growth of 20 Percent

MINNEAPOLIS, May 25, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT): First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP...
May 25, 2010

Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve(R) Transcatheter Aortic Valve System

Data Demonstrates That Revolutionary Treatment for Patients with Diseased Heart Valves Is Transitioning Successfully into Standard Clinical Practice throughout Europe

PARIS, May 25, 2010 (BUSINESS WIRE) --New European data from five national clinical registries presented today at EuroPCR report positive clinical outcomes for one of the most exciting emerging...
May 25, 2010

Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study

One-Year Clinical Results from Innovative RESOLUTE All Comers Trial Show Excellent Performance for Resolute DES in Challenging Patient Population

PARIS, May 25, 2010 (BUSINESS WIRE) --The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR...
May 20, 2010

Medtronic Announces 2010 Analyst Meeting and Webcast

Medtronic Institutional Investor and Analyst Meeting Scheduled for Monday, June 7, 2010, 10 a.m. - 2:30 p.m. Eastern

MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Monday, June 7, 2010, in New York City from 10 a.m. - 2:30 p.m. Eastern...
May 20, 2010

Cardiovascular Devices from Medtronic Featured Prominently at EuroPCR

Cardiology Meeting in Paris May 25-28 Includes New Data on Resolute(R) Drug-Eluting Stent, IN.PACT Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking...
May 19, 2010

First Patient Treated with Valiant(R) Thoracic Stent Graft in Medtronic's ''RESCUE'' Clinical Study

Minimally-Invasive Procedure May Stabilize Aortic Bleeding When Surgery Is Not an Option

MINNEAPOLIS, May 19, 2010 (BUSINESS WIRE) --Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc. (NYSE: MDT), today announced that the...
May 17, 2010

Medtronic CFO Gary Ellis to Speak at the Citi Global Health Care Conference

MINNEAPOLIS, May 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 2010 Citi Investment Research Global Health Care Conference on Wednesday, May...

Show per page